Peer-influenced content. Sources you trust. No registration required. This is HCN.

ALK-Rearranged NSCLC Linked to Higher Venous and Arterial Thrombotic Risk

The findings, recently published in the Journal of Thoracic Oncology, suggested that patients with ALK rearrangements may benefit from prophylactic anticoagulation, and venous thromboembolism risk prediction scores may improve if ALK rearrangement status is incorporated.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form